माल्टा -
अंग्रेज़ी -
Medicines Authority
femoston conti 0.5mg/2.5mg film-coated tablets
bgp products ltd - dydrogesterone 2.5 mg, estradiol 0.5 mg - film-coated tablet
आयरलैंड -
अंग्रेज़ी -
HPRA (Health Products Regulatory Authority)
femoston-conti 0.5/2.5 milligram film coated tablet
abbott healthcare products ltd - estradiol dydrogesterone - film coated tablet - 0.5/2.5 milligram
इसराइल -
अंग्रेज़ी -
Ministry of Health
femoston 110 mg
abbott medical laboratories ltd, israel - dydrogesterone; estradiol; estradiol - film coated tablets - dydrogesterone 10 mg; estradiol 1 mg; estradiol 1 mg - dydrogesterone and estrogen - hormone replacement therapy (hrt) for estrogen deficiency symptoms in menopausal women at least 6 months since last menses.prevention of osteoporosis in postmenopausal women at high risk of future fractures. femoston 1/10 should only be used in patients who are intolerant of other products, approved for the prevention of osteoporosis or for whom these products are contra-indicated.femoston is indicated for women with an intact uterusexperience with treatment of women older than 65 years is limited.